7
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Investigation into an engraftment defect induced by culturing primitive hematopoietic cells with cytokines

, , , , , , & show all
Pages 307-320 | Published online: 07 Jul 2009

References

  • Young JC, Bruno E, Luens KM et al. Thrombopoietin stim-ulates megakaryocytopoiesis, myelopoiesis and expansion of primitive CD34+ progenitor cells from single CD34+Thy-1+Lin— primitive progenitor cells. Blood 1996;88:1619–31.
  • Borge 0J, Ramsfjell V, Cui L et al. Ability of early acting cytokines to directly promote survival and suppress apopto-sis of human primitive CD34+CD38— bone marrow cells with multilineage potential at the single cell level: key role of thrombopoietin. Blood 1997;90: 2282–92.
  • Haylock DN, Horsfall MJ, Dowse TL et al. Increased recruitment of hemopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood 1997;90:2260–72.
  • Piacibello W, Sanavio F, Garetto L et al. Extensive amplifi-cation and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2649–53.
  • Murray LJ, Young JC, Osborne LJ et al. Thrombopoietin, flt3and kit ligands together suppress apoptosis of human mobi-lized CD34+ cells and recruit primitive CD34+Thy-1+ cells into rapid division. Exp Hematol 1999;27:1019–28.
  • Luens KM, Travis MA, Chen BP et al. Thrombopoietin, kit ligand and flk2/flt3 ligand together induce increased num-bers of primitive hematopoietic progenitors from human CD34+Thy-1+ Lin— cells with preserved ability to engraft in SCID-hu bone. Blood 1998;91:1206–15.
  • Young JC, Tushinski RJ, Hill BL et al. Progress in ex vivo replication of hematopoietic stem cells. Recent Res Dev Biotech Bioeng 1998;1:433–47.
  • Baum CM, Weissman I, Tsukamoto A et al. Isolation of a candidate human hematopoietic stem cell population. Proc Nail Acad Sci. USA 1992;89:2804–8.
  • Craig W, Kay R, Cutler RL et al. Expression of Thy-1 on human hematopoietic progenitor cells. 7 Exp Med 1993;177:1331.
  • Murray L, Chen B, Galy A et al. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin—subpopulation from mobilized peripheral blood. Blood 1995;85:368–78.
  • Uchida N, Aguila HL, Fleming WH et al. Rapid and sus-tained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-1.11°Lin— S ca-1 + hema-topoietic stem cells. Blood 1994;83:3758–79.
  • Nibley WE, Spangrude GJ. Primitive stem cells alone medi-ate rapid marrow-recovery and multilineage engraftment after transplantation. Bone Marrow Transplant 1998;21: 345–54.
  • Mishallet M, Philip T, Philip I et al. Transplantation with selected autologous peripheral blood CD34+Thy-1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol 2000;28:858–70.
  • Negrin RS, Atkinson K, Leemhuis T et al. Transplantation of highly purified CD34+ Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant 2000;6:262–71.
  • Young JC, Lin K, Hansteen G et al. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo. Exp Hematol 1999;27:994–1003.
  • Uchida N, He D, Friera AM et al. The unexpected GO/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 1997;89:465–72.
  • Lemoli RM, Tafuri A, Fortuna A et al. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimu-lating factor. Blood 1997;89:1189–96.
  • Williams CD, Linch DC, Watts MJ et al. Characterization of cell cycle status and E2F complexes in mobilized CD 34 + cells before and after cytokine stimulation. Blood1997;90:194–203.
  • Bachier CR, Gokmen E, Teale J et al. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitu-tion following high-dose chemotherapy for breast cancer. Exp Hematol 1999;27:615–23.
  • Watanabe T, Dave B, Heimann DG et al. Cell adhesion mol-ecule expression on CD 34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation. Exp Hematol 1998;26:10–18.
  • Derchsen MW, Gerritsen WR, Rodenhuis S et al. Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation. Blood 1995;85:3313–19.
  • Orschell Traycoff CM, Hiatt K, Dagher RN et al. Homing and engraftment potential of Sca-1(± )1in( - ) cells fraction-ated on the basis of adhesion molecule expression and position in the cell cycle. Blood 2000;96:1380–7.
  • Zou Y-R, Kottmann AH, Kuroda M et al. Function of the chemokine receptor CXCR-4 in haematopoiesis and in cerebellar development. Nature 1988;393:595–9.
  • Kawabata K, Ujikawa M, Egawa T et al. A cell-autonomous requirement for CXCR-4 in long-term lymphoid and myeloid reconstitution. Proc Natl Acad Sci USA 1999;96:5663–7.
  • Ma Q, Jones D, Springer TA. The chemokine receptor CXCR-4 is required for the retention of B lineage and gran-ulocytic precursors within the bone marrow micro-environment. Immunio 1999;10: 463–71.
  • Hirsch E, Iglesias A, Potocnik AJ et a/. Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta-1 integrins. Nature 1996;380:171–5.
  • Papayannapoulou T, Nakamoto B. Peripheralization of hemopoietic progenitors in primates treated with anti-VLA-4 integrin. Proc Natl Acad Sci USA 1993;90:9379–8.
  • Papayannapoulou T, Priestley GV, Nakamoto B. Anti-VLA-4/VCAM-1 - induced mobilization required cooperative signaling through the kit/mkit ligand pathway. Blood 1998;91: 2231–9.
  • Vermeulen M, Le Pesteur F, Gagnerault M-C et al. Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 1998;92:899–900.
  • Frenette PS, Sabbarao S, Mazo IB et al. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoi-etic progenitor homing to the bone marrow. Proc Natl Acad Sci USA 1998;95:14423–8.
  • Peled A, Kollet 0, Ponomaryov T et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4 and VLA-5 on immature human CD34+ cells: role in transendothelial/ stromal migration and engraftment of NOD/SCID mice. Blood 2000;95: 3289–96.
  • Domen J, Weissman IL. Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol Med Today 1999;5:201–8.
  • Boldin WD, Goncharov BM, Goltsev Y et al. Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family. BehringInst Mitt 1996;97:144.
  • Traycoff CM, Orazi A, Ladd AC et al. Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol 1998;26:53–62.
  • Young JC, Varma A, DiGiusto D et al. Retention of quies-cent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 1996;87:545–56.
  • Humeau L, Chabannon C, Bardin F et al. Cytokine expo-sure alters the haematopoietic potential of mobilised human blood CD34+ progenitors, as evaluated with engraftment in SCID-hu mice. Br y Haematol 1996;93:336a.
  • McCune JM, Namikawa R, Kaneshima H et al The SCID-hu mouse: murine model for the analysis of human hematolym-phoid differentiation and function. Science 1988;241:1632–9.
  • Arai H, Tsou CL, Charo IF. Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evi-dence that directed migration is mediated by betagamma dimmers released by activation of Galphai-coupled recep-tors. Proc Natl Acad Sci USA 1997;94: 1495–9.
  • Abitorabi A, Pachynski M, Ferrando RK et al. Presentation of integrins on leukocyte microvilli: a role for the extracel-lular domain in determining membrane localization. 7 Cell Biol 1997;139:563–71.
  • Leung W, Ramirez M, Civin C. Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. Biol Blood Marrow Transplant 1999;5:69–76.
  • Simmons PJ, Levesque JP, Zannettino ACW. Adhesion mol-ecules in haemopoiesis. Baill Clin Haematol 1997;10:485–505.
  • Whetton AD, Graham GJ. Homing and mobilization in the stem cell niche. Trends Cell Biol 1999;9:233–8.
  • Mobest D, Groan S-R, Junghahn I et al Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Stem Cells 1999;17:152–61.
  • Bhatia M, Bonnet D, Kapp U et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. 7 Exp Med 1997;186:619–24.
  • Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopu-lating activity in nonobese diabetic-scidircid mice. Proc Natl Acad Sci USA 1997;94:9836–41.
  • Hueber A-0, Bernard A-M, Langlet-El BC et al. Thymocytes in Thy-1-1 - mice show augmented TCR signaling and impaired differentiation. Curr Bio11997;7: 705–8.
  • Peled A, Petit I, Kollet 0 et al. Dependence of human stem cell engraftment and repopulation of NOD-SCID mice on CXCR-4. Science 1999;283:845–8.
  • Wiesmann AW, Spangrude GJ. Marrow engraftment of hematopoietic stem and progenitor cells is independent of G alpharcoupled chemokine receptors. Exp Hematol 1999;27:946–55.
  • Stahnke K, Hecker S, Kohne E et al. CD95 (AP0-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells. Exp Hematol 1998;26:849–50.
  • Takenaka K, Nagafuji K, Harada M et al. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95). Blood 1996;88:2871–7.
  • Barcena A, Muench MO, Song KS et al. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34±±CD38— fetal liver cells. Exp Hematol 1999;27: 1428–39.
  • Josefsen D, Hyklebust JH, Lynch DH et al. Fas ligand pro-motes cell survival of immature human bone marrow CD34±CD38— hematopoietic progenitor cells by suppress-ing apoptosis. Exp Hematol 1999;27:1451–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.